ESC Premium Access

Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome in metabolic syndrome in mice

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Congress Presentation

About the speaker

Mr Julian Merz

University of Freiburg, Freiburg (Germany)
0 follower

5 more presentations in this session

A novel senolytic drug, seno-7284 ameliorates age-related cardiometabolic diseases

Speaker: Doctor G. Katsuumi (Tokyo, JP)


Maternal high-fat diet exaggerates the development of diet-induced insulin resistance in adult offspring by enhancing pyroptosis through augmented gasdermin D-mediated pore formation

Speaker: Doctor N. Wada (Kyoto, JP)


A distinct LDL profile to predict the risk of cardiovascular disease in familial hypercholesterolemia subjects: initial pre-clinical results

Speaker: Miss A. Hoogendoorn (Adelaide, AU)


Endothelial mitochondrial fragmentation contributes to vascular dysfunction in hypertension

Speaker: Associate Professor X. Zhang (Xi'an, CN)


Endothelial autophagy triggers nuclear enrichment of miR-126-5p via a Mex3a-dependent pathway to confers endothelial protection and prevent atherosclerosis.

Speaker: Doctor D. Santovito (Munich, DE)


Access the full session

Metabolic interfaces in vascular disease

Speakers: Mr J. Merz, Doctor G. Katsuumi, Doctor N. Wada, Miss A. Hoogendoorn, Associate Professor X. Zhang...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb